Home > Offer to Sell > Inorganic chemicals > Inorganic acids > Memory Enhancement Nootropic Agent Smart Drugs Noopept
Memory Enhancement Nootropic Agent Smart Drugs Noopept
Inquiry
| Post Date: | Jan 18,2018 |
| Expiry Date: | Jul 17,2018 |
| Detailed Description: |
Product Name:Noopept
Noopept CAS NO.:157115-85-0 Noopept Molecular Formula:C17H22N2O4 Noopept Molecular Weight:318.3676 Noopept Purity:99% Noopept Grade:Food Grade Noopept Appearance:white powder Function:Enhances brain activity,strenthens memory,increase ability to fucus,increase the ability to learn Noopept is not a racetam (due to not having a 2-oxo-pyrrolidine skeleton),but is generally grouped together in the same category because it shares similar mechanisms of action with the racetam family, mainly modulation of the acetylcholine system, as well as modulation of AMPA receptors. It has close ties to the popular racetam family of nootropics that are known for their benefits on cognitive ability as well their neuroprotective properties. What makes Noopept a valuable nootropic in your toolbox is that its effects are felt almost immediately after ingestion.When compared to traditional racetams, it has been found to be, according to studies, 1000 times more potent than the prototypical racetam drug, piracetam.Noopept is a prodrug for the endogenous peptide cycloprolylglycine.As a result, Noopept can be taken in comparably smaller doses to produce the same results as that of Piracetam. |
| Company: | Wuhan Yuancheng Technology Co.,LTD [ China ] |
| Contact: | mariah |
| Tel: | 15872388127 |
| Fax: | |
| Email: | mariah@ycphar.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
